0002058052-25-000003.txt : 20250228 0002058052-25-000003.hdr.sgml : 20250228 20250227205324 ACCESSION NUMBER: 0002058052-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250228 DATE AS OF CHANGE: 20250227 EFFECTIVENESS DATE: 20250228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Maxymune Therapeutics, Inc. CENTRAL INDEX KEY: 0002058052 ORGANIZATION NAME: IRS NUMBER: 933707815 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-539494 FILM NUMBER: 25682162 BUSINESS ADDRESS: STREET 1: 95 MAIN ST. STREET 2: SUITE 9 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-892-1942 MAIL ADDRESS: STREET 1: 95 MAIN ST. STREET 2: SUITE 9 CITY: LOS ALTOS STATE: CA ZIP: 94022 D 1 primary_doc.xml X0708 D LIVE 0002058052 Maxymune Therapeutics, Inc. 95 MAIN ST. SUITE 9 LOS ALTOS CA CALIFORNIA 94022 650-892-1942 DELAWARE Transplant RX, Inc. None Corporation true 2023 Gordon Ringold 1744 GROUSE RIDGE RD Truckee CA CALIFORNIA 96161 Executive Officer Director Neil Solomons 5553 PARKER AVE Victoria A1 BRITISH COLUMBIA, CANADA V8Y 2N2 Director Tatjana Naranda 27343 URSULA LANE Los Altos CA CALIFORNIA 94022 Executive Officer Biotechnology No Revenues 06b false 2025-02-11 false true false 10000 2500000 850000 1650000 false 8 0 0 0 false Maxymune Therapeutics, Inc. Tatjana Naranda Tatjana Naranda President & COO 2025-02-27